1 patient evaluation for Natalizumab taken for the purpose of 'Improve mobility' with a perceived effectiveness rating of None

8 members have decided to share their profiles only with other members of PatientsLikeMe.

Feb 27, 2017 (Started Jan 15, 2011)

  • Effectiveness
    Major (for multiple sclerosis)
  • Effectiveness
    None (for Improve mobility)
  • Effectiveness
    Major (for General health)
  • Side effects
    Moderate (bowel problems, walking slower)
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Dosage: 300 mg/15 mL every 4 weeks
Advice & Tips: I completed almost five years on Tysabri. Unfortunately I was diagnosed with breast cancer this month. had to stop it and move to Rebif.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Natalizumab